Novadip Biosciences Raises Additional EUR 40 Million Bringing Total Company Funding to EUR 88 Million
MONT SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Novadip Biosciences (“Novadip” or “the Company”), a clinical-stage biopharmaceutical company developing a new class of regenerative tissue products to accelerate healing of large bone defects and injuries...